Stem definition | Drug id | CAS RN |
---|---|---|
anti-infectives, sulfonamides | 4142 | 22199-08-2 |
Molecule | Description |
---|---|
Synonyms:
|
Antibacterial used topically in burn therapy.
|
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Nov. 26, 1973 | FDA | KING PHARMS |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Drug hypersensitivity | 248.01 | 18.16 | 153 | 2345 | 250857 | 50351769 |
PRIDE syndrome | 29.23 | 18.16 | 4 | 2494 | 16 | 50602610 |
Oral lichen planus | 21.22 | 18.16 | 5 | 2493 | 533 | 50602093 |
Cellulitis | 20.22 | 18.16 | 21 | 2477 | 70777 | 50531849 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Drug hypersensitivity | 93.15 | 24.97 | 50 | 1285 | 68356 | 29504836 |
Toxic epidermal necrolysis | 90.17 | 24.97 | 33 | 1302 | 18120 | 29555072 |
Skin graft failure | 28.24 | 24.97 | 5 | 1330 | 139 | 29573053 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Drug hypersensitivity | 236.30 | 19.23 | 149 | 3223 | 237666 | 64257694 |
Toxic epidermal necrolysis | 68.29 | 19.23 | 35 | 3337 | 37131 | 64458229 |
Cellulitis | 31.21 | 19.23 | 31 | 3341 | 93626 | 64401734 |
PRIDE syndrome | 29.00 | 19.23 | 4 | 3368 | 16 | 64495344 |
Skin graft failure | 25.25 | 19.23 | 5 | 3367 | 221 | 64495139 |
Oral lichen planus | 19.76 | 19.23 | 5 | 3367 | 676 | 64494684 |
None
Source | Code | Description |
---|---|---|
ATC | D06BA01 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE Sulfonamides |
ATC | D06BA51 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE Sulfonamides |
FDA CS | M0020790 | Sulfonamides |
FDA EPC | N0000175503 | Sulfonamide Antibacterial |
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D000891 | Anti-Infective Agents, Local |
CHEBI has role | CHEBI:33281 | antibiotics |
CHEBI has role | CHEBI:36047 | antibacterial drugs |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Skin ulcer | indication | 46742003 | |
Burn Wound Infections | indication | ||
Minor Bacterial Skin Infections | indication | ||
Leukopenia | contraindication | 84828003 | DOID:615 |
Kidney disease | contraindication | 90708001 | DOID:557 |
Anemia due to enzyme deficiency | contraindication | 111577008 | |
Deficiency of glucose-6-phosphate dehydrogenase | contraindication | 124134002 | DOID:2862 |
Superimposed infection | contraindication | 193198003 | |
Disease of liver | contraindication | 235856003 | DOID:409 |
Anemia | contraindication | 271737000 | DOID:2355 |
Pregnancy, function | contraindication | 289908002 | |
Thrombocytopenic disorder | contraindication | 302215000 | DOID:1588 |
Porphyria | contraindication | 418470004 |
Species | Use | Relation |
---|---|---|
Dogs | Otitis externa complicated by bacterial and fungal organisms | Indication |
Product | Applicant | Ingredients |
---|---|---|
Baytril Otic | Elanco US Inc. | 2 |
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Aurora kinase A | Kinase | IC50 | 4.68 | CHEMBL | |||||
Dihydropteroate synthase | Enzyme | INHIBITOR | CHEMBL | CHEMBL |
ID | Source |
---|---|
4018504 | VUID |
N0000146826 | NUI |
D00433 | KEGG_DRUG |
4018504 | VANDF |
C0037134 | UMLSCUI |
CHEBI:9142 | CHEBI |
CHEMBL1382627 | ChEMBL_ID |
441244 | PUBCHEM_CID |
DB05245 | DRUGBANK_ID |
CHEMBL439 | ChEMBL_ID |
W46JY43EJR | UNII |
224926 | RXNORM |
1640 | MMSL |
1649 | MMSL |
5463 | MMSL |
003135 | NDDF |
19630009 | SNOMEDCT_US |
387112002 | SNOMEDCT_US |
D012837 | MESH_DESCRIPTOR_UI |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0440-0124 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
SSD | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16590-206 | CREAM | 10 g | TOPICAL | NDA | 14 sections |
ThermazeneSilver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-182 | CREAM | 10 mg | TOPICAL | NDA | 11 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 33261-589 | CREAM | 10 mg | TOPICAL | NDA | 16 sections |
Silver Sulfadiazene | HUMAN PRESCRIPTION DRUG LABEL | 1 | 42254-118 | CREAM | 10 g | TOPICAL | NDA | 16 sections |
SSD Cream | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43598-210 | CREAM | 10 g | TOPICAL | NDA | 11 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45865-642 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 49999-185 | CREAM | 10 g | TOPICAL | ANDA | 19 sections |
SILVADENE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0230 | CREAM | 10 mg | TOPICAL | NDA | 19 sections |
SILVADENE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0230 | CREAM | 10 mg | TOPICAL | NDA | 19 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0607 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0717 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0717 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0763 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-2152 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50436-1240 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazene | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50436-3099 | CREAM | 10 g | TOPICAL | NDA | 16 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52959-635 | CREAM | 10 g | TOPICAL | NDA | 14 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-9090 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Thermazene | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53097-101 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-0375 | CREAM | 10 mg | TOPICAL | NDA | 14 sections |
SSD Cream | HUMAN PRESCRIPTION DRUG LABEL | 1 | 55700-640 | CREAM | 10 g | TOPICAL | NDA | 11 sections |
SILVER SULFADIAZINE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 59762-0131 | CREAM | 10 mg | TOPICAL | NDA AUTHORIZED GENERIC | 21 sections |
SILVADENE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 61570-131 | CREAM | 10 mg | TOPICAL | NDA | 19 sections |
SILVER SULFADIAZINE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 61919-206 | CREAM | 10 mg | TOPICAL | NDA | 12 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 61919-237 | CREAM | 10 g | TOPICAL | NDA | 11 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63187-023 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63187-023 | CREAM | 10 mg | TOPICAL | NDA | 17 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8768 | CREAM | 10 mg | TOPICAL | NDA | 16 sections |
Silver Sulfadiazine | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8768 | CREAM | 10 mg | TOPICAL | NDA | 16 sections |